Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 5
Submit an article Journal homepage
173
Views
8
CrossRef citations to date
0
Altmetric
Review

The pharmacological treatment of primary aldosteronism

Salim Janmohamed Honorary Senior Lecturer in Endocrinology, Department of Endocrinology, Royal Free Hospital, London, NW3 2QG, UK
&
Pierre-Marc G Bouloux Professor of Endocrinology, Department of Endocrinology, Royal Free Hospital, London, NW3 2QG, UK. [email protected]
Pages 563-573 | Published online: 23 Mar 2006

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

A. Syngle, K. Vohra, L. Kaur & S. Sharma. (2009) Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis. Scandinavian Journal of Rheumatology 38:1, pages 15-22.
Read now
Asterios Karagiannis, Konstantinos Tziomalos, Athanasios Papageorgiou, Anna I Kakafika, Efstathios D Pagourelias, Panagiotis Anagnostis, Vasilios G Athyros & Dimitri P Mikhailidis. (2008) Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opinion on Pharmacotherapy 9:4, pages 509-515.
Read now

Articles from other publishers (6)

Yuta Tezuka & Adina F. Turcu. (2021) Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism. Frontiers in Endocrinology 12.
Crossref
V. O. Shidlovskyі, O. V. Shidlovsky, O. A. Tovkai, I. M. Pavlovskyi & V. V. Kravtsiv. (2020) МЕДИКАМЕНТОЗНЕ ЛІКУВАННЯ ПЕРВИННОГО ГІПЕРАЛЬДОСТЕРОНІЗМУ. Здобутки клінічної і експериментальної медицини:4, pages 6-14.
Crossref
Cesar Luiz Boguszewski, Alexandre Alessi & Mauricio Carvalho. 2014. Endocrinology and Diabetes. Endocrinology and Diabetes 127 143 .
Tracy-Ann Moo, Rasa Zarnegar & Quan-Yang Duh. (2007) Prediction of Successful Outcome in Patients with Primary Aldosteronism. Current Treatment Options in Oncology 8:4, pages 314-321.
Crossref
Susan J. HoodKevin P. TaylorMichael J. AshbyMorris J. Brown. (2007) The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio. Circulation 116:3, pages 268-275.
Crossref
Carolyn D Bubbar, David F Blackburn, Merne P Wilson & Thomas W Wilson. (2016) Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hypertension Due to Primary Aldosteronism: A Case for Exclusion. Annals of Pharmacotherapy 41:1, pages 129-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.